Vaccine injection site histology
In order to identify immune cell infiltration into vaccine injection site, excision-biopsy tissue from subject 11-10 was sectioned and stained with standard H&E and by immunohistochemistry (IHC). For IHC, sections were stained with primary antibodies against human CD3, CD4, CD8 and CD19, followed by biotinylated secondary antibody, ABC reagent and DAB substrate.
Comparison of modified and native peptides in ELISPOT and tetramer assay
To ascertain modified peptides in the vaccine could generate native peptide reactive T cells, both versions of HLA-A1, A2 and A3 peptides were tested in parallel in ELISPOT and in vitro activated CD8 T cell tetramer staining. For ELISPOT assay, PBMC were stimulated overnight with either modified or native peptides and IFN- SFU was determined as outlined for Injection site histology was performed on one of the subjects (11-10, cohort C) presenting with lipodystrophy and skin ulceration. The excisional biopsy showed an ulcer associated with needle tract and foreign body granuloma. Based on H&E stain, the epidermis was reported to be unremarkable, but the dermis showed a perivascular lymphocytic infiltrate with eosinophils suggestive of a hypersensitivity reaction. The biopsy was also used in immunohistochemistry for analyzing lymphocyte infiltration, which showed the infiltration of CD4/CD8 T cells but no B cells.
Supplementary Fig. 2: Cross reactivity of patient T cells induced by modified peptides contained in
DPX-Survivac to native survivin peptides. In order to ascertain that modified survivin peptides in DPXSurvivac have the ability to generate antigen-specific CD8 T cells that can cross react with corresponding native peptides, ELISPOT (a) and tetramer (b, c) assays were done in parallel using either modified or native HLA-A1, -A2 and -A3 peptides. The results indicate that vaccine-induced T cells react with native peptides as compared to modified peptides in IFN- ELISPOT assay (upper panel) and expand tetramer positive CD8 T cells in response to native peptide stimulation (lower panel). b, A2 tetramer used was based on modified peptide and in c, A2 tetramer versions used were corresponding to the peptide version used for stimulation. *denotes events occurring in same subject;  denotes events occurring in same subject
